Institute for Biomedical Ethics, University of Basel, Bernoullistrasse 28, 4056, Basel, Switzerland.
Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH, Zurich, Switzerland.
Sci Eng Ethics. 2018 Aug;24(4):1035-1055. doi: 10.1007/s11948-017-9976-1. Epub 2017 Sep 22.
The use of Intelligent Assistive Technology (IAT) in dementia care opens the prospects of reducing the global burden of dementia and enabling novel opportunities to improve the lives of dementia patients. However, with current adoption rates being reportedly low, the potential of IATs might remain under-expressed as long as the reasons for suboptimal adoption remain unaddressed. Among these, ethical and social considerations are critical. This article reviews the spectrum of IATs for dementia and investigates the prevalence of ethical considerations in the design of current IATs. Our screening shows that a significant portion of current IATs is designed in the absence of explicit ethical considerations. These results suggest that the lack of ethical consideration might be a codeterminant of current structural limitations in the translation of IATs from designing labs to bedside. Based on these data, we call for a coordinated effort to proactively incorporate ethical considerations early in the design and development of new products.
在痴呆症护理中使用智能辅助技术 (IAT) 为降低全球痴呆症负担和为改善痴呆症患者的生活提供新机会开辟了前景。然而,据报道,目前的采用率较低,只要未解决采用率不理想的原因,IAT 的潜力可能仍未得到充分发挥。其中,伦理和社会方面的考虑至关重要。本文综述了痴呆症的 IAT 范围,并研究了当前 IAT 设计中伦理考虑的普遍性。我们的筛选结果表明,当前相当一部分的 IAT 是在没有明确的伦理考虑的情况下设计的。这些结果表明,缺乏伦理考虑可能是当前将 IAT 从设计实验室转化为床边的结构性限制的一个决定因素。基于这些数据,我们呼吁协调努力,在新产品的设计和开发早期就积极纳入伦理考虑。